Neurovascular Devices Market Size, Share, Growth & Industry Analysis, By Device Type (Trans Radial Access Devices, Neurothrombectomy Devices, Cerebral Angioplasty & Stenting Systems, Cerebral Embolization & Aneurysm Coiling Devices, Support Devices), By Application (Cerebral Aneurysm, Others), By End User and Regional Analysis, 2024-2031

TABLE OF CONTENT

1 INTRODUCTION OF THE GLOBAL NEUROVASCULAR DEVICES MARKET 
1.1 Market Definition
1.2 Market Segmentation
1.3 Research Timelines
1.4 Limitations
1.5 Assumptions

2 EXECUTIVE SUMMARY

3 RESEARCH METHODOLOGY
3.1 Data Collection
3.1.1 Secondary Sources
3.1.2 Primary Sources
3.1.3 Research Flow
3.2 Subject Matter Expert Advice
3.3 Quality Check
3.4 Final Review
3.5 Bottom-Up Approach
3.6 Top-down Approach

4 GLOBAL NEUROVASCULAR DEVICES MARKET OUTLOOK
4.1 Market Evolution
4.2 Overview
4.3 Market Dynamics
4.3.1 Drivers
4.3.2 Restraints
4.3.3 Opportunities
4.3.4 Challenges
4.4 Pricing Analysis
4.5 Porter’s Five Forces Analysis
4.6 Value Chain Analysis
4.7 Macroeconomic Analysis

5 IMPACT OF RUSSIA-UKRAINE WAR

6 GLOBAL NEUROVASCULAR DEVICES MARKET, BY DEVICE TYPE
6.1 Overview
6.2 Trans Radial Access Devices
6.3 Neurothrombectomy Devices
6.4 Cerebral Angioplasty & Stenting Systems
6.5 Cerebral Embolization & Aneurysm Coiling Devices
6.6 Support Devices

7 GLOBAL NEUROVASCULAR DEVICES MARKET, BY APPLICATION
7.1 Overview
7.2 Cerebral Aneurysm
7.3 Ischemic Strokes
7.4 Carotid Artery Stenosis
7.5 Others

8 GLOBAL NEUROVASCULAR DEVICES MARKET, BY END USER
8.1 Overview
8.2 Hospitals
8.3 Specialty Care Centers
8.4 Others

9 GLOBAL NEUROVASCULAR DEVICES MARKET, BY GEOGRAPHY
9.1 Overview

10 NORTH AMERICA 
10.1 U.S.
10.2 Canada
10.3 Mexico

11 EUROPE 
11.1 Germany
11.2 U.K.
11.3 France
11.4 Italy
11.5 Spain
11.6 Russia
11.7 Rest of Europe

12 ASIA-PACIFIC 
12.1 China
12.2 Japan
12.3 India
12.4 South Korea
12.5 Rest of Asia-Pacific

13 MIDDLE EAST & AFRICA 
13.1 GCC
13.2 South Africa
13.3 North Africa
13.4 Rest of Middle East & Africa

14 LATIN AMERICA 
14.1 Brazil
14.2 Argentina
14.3 Rest of South America

15 GLOBAL NEUROVASCULAR DEVICES MARKET COMPETITIVE LANDSCAPE
15.1 Overview
15.2 Key Developments
15.3 Key Strategic Developments
15.4 Company Market Ranking
15.5 Regional Footprint
15.6 Industry Footprint

16 COMPANY PROFILES
16.1 Stryker
16.1.1 Key Facts
16.1.2 Financial Overview
16.1.3 Product Benchmarking
16.1.4 Recent Developments
16.1.5 Winning Imperatives
16.1.6 Current Focus & Strategies
16.1.7 Threat from competition
16.1.8 SWOT Analysis
16.2 Medtronic
16.2.1 Key Facts
16.2.2 Financial Overview
16.2.3 Product Benchmarking
16.2.4 Recent Developments
16.2.5 Winning Imperatives
16.2.6 Current Focus & Strategies
16.2.7 Threat from competition
16.2.8 SWOT Analysis
16.3 Penumbra, Inc.
16.3.1 Key Facts
16.3.2 Financial Overview
16.3.3 Product Benchmarking
16.3.4 Recent Developments
16.3.5 Winning Imperatives
16.3.6 Current Focus & Strategies
16.3.7 Threat from competition
16.3.8 SWOT Analysis
16.4 MicroPort Medical (Group) Co., Ltd.
16.4.1 Key Facts
16.4.2 Financial Overview
16.4.3 Product Benchmarking
16.4.4 Recent Developments
16.4.5 Winning Imperatives
16.4.6 Current Focus & Strategies
16.4.7 Threat from competition
16.4.8 SWOT Analysis
16.5 Terumo Corporation
16.5.1 Key Facts
16.5.2 Financial Overview
16.5.3 Product Benchmarking
16.5.4 Recent Developments
16.5.5 Winning Imperatives
16.5.6 Current Focus & Strategies
16.5.7 Threat from competition
16.5.8 SWOT Analysis
16.6 B. Braun SE
16.6.1 Key Facts
16.6.2 Financial Overview
16.6.3 Product Benchmarking
16.6.4 Recent Developments
16.7 Acandis GmbH
16.7.1 Key Facts
16.7.2 Financial Overview
16.7.3 Product Benchmarking
16.7.4 Recent Developments
16.8 W. L. Gore & Associates, Inc.
16.8.1 Key Facts
16.8.2 Financial Overview
16.8.3 Product Benchmarking
16.8.4 Recent Developments
16.9 Integra LifeSciences Corporation
16.9.1 Key Facts
16.9.2 Financial Overview
16.9.3 Product Benchmarking
16.9.4 Recent Developments
16.10 Abbott
16.10.1 Key Facts
16.10.2 Financial Overview
16.10.3 Product Benchmarking
16.10.4 Recent Developments

LIST OF TABLES

TABLE 1 Global Neurovascular Devices Market Revenue, By Device Type, 2021 – 2031 (USD Billion)
TABLE 2 Global Neurovascular Devices Market Revenue, By Application, 2021 – 2031 (USD Billion)
TABLE 3 Global Neurovascular Devices Market Revenue, By End Use, 2021 – 2031 (USD Billion)
TABLE 4 Global Neurovascular Devices Market Revenue, By Geography, 2021 – 2031 (USD Billion)
TABLE 5 North America Neurovascular Devices Market Revenue, By Country, 2021 – 2031 (USD Billion)
TABLE 6 North America Neurovascular Devices Market Revenue, By Device Type, 2021 – 2031 (USD Billion)
TABLE 7 North America Neurovascular Devices Market Revenue, By Application, 2021 – 2031 (USD Billion)
TABLE 8 North America Neurovascular Devices Market Revenue, By End Use, 2021 – 2031 (USD Billion)
TABLE 9 US Neurovascular Devices Market Revenue, By Device Type, 2021 – 2031 (USD Billion)
TABLE 10 US Neurovascular Devices Market Revenue, By Application, 2021 – 2031 (USD Billion)
TABLE 11 US Neurovascular Devices Market Revenue, By End Use, 2021 – 2031 (USD Billion)
TABLE 12 Canada Neurovascular Devices Market Revenue, By Device Type, 2021 – 2031 (USD Billion)
TABLE 13 Canada Neurovascular Devices Market Revenue, By Application, 2021 – 2031 (USD Billion)
TABLE 14 Canada Neurovascular Devices Market Revenue, By End Use, 2021 – 2031 (USD Billion)
TABLE 15 Mexico Neurovascular Devices Market Revenue, By Device Type, 2021 – 2031 (USD Billion)
TABLE 16 Mexico Neurovascular Devices Market Revenue, By Application, 2021 – 2031 (USD Billion)
TABLE 17 Mexico Neurovascular Devices Market Revenue, By End Use, 2021 – 2031 (USD Billion)
TABLE 18 Europe Neurovascular Devices Market Revenue, By Country, 2021 – 2031 (USD Billion)
TABLE 19 Europe Neurovascular Devices Market Revenue, By Device Type, 2021 – 2031 (USD Billion)
TABLE 20 Europe Neurovascular Devices Market Revenue, By Application, 2021 – 2031 (USD Billion)
TABLE 21 Europe Neurovascular Devices Market Revenue, By End Use, 2021 – 2031 (USD Billion)
TABLE 22 Germany Neurovascular Devices Market Revenue, By Device Type, 2021 – 2031 (USD Billion)
TABLE 23 Germany Neurovascular Devices Market Revenue, By Application, 2021 – 2031 (USD Billion)
TABLE 24 Germany Neurovascular Devices Market Revenue, By End Use, 2021 – 2031 (USD Billion)
TABLE 25 France Neurovascular Devices Market Revenue, By Device Type, 2021 – 2031 (USD Billion)
TABLE 26 France Neurovascular Devices Market Revenue, By Application, 2021 – 2031 (USD Billion)
TABLE 27 France Neurovascular Devices Market Revenue, By End Use, 2021 – 2031 (USD Billion)
TABLE 28 U.K. Neurovascular Devices Market Revenue, By Device Type, 2021 – 2031 (USD Billion)
TABLE 29 U.K. Neurovascular Devices Market Revenue, By Application, 2021 – 2031 (USD Billion)
TABLE 30 U.K. Neurovascular Devices Market Revenue, By End Use, 2021 – 2031 (USD Billion)
TABLE 31 Spain Neurovascular Devices Market Revenue, By Device Type, 2021 – 2031 (USD Billion)
TABLE 32 Spain Neurovascular Devices Market Revenue, By Application, 2021 – 2031 (USD Billion)
TABLE 33 Spain Neurovascular Devices Market Revenue, By End Use, 2021 – 2031 (USD Billion)
TABLE 34 Italy Neurovascular Devices Market Revenue, By Device Type, 2021 – 2031 (USD Billion)
TABLE 35 Italy Neurovascular Devices Market Revenue, By Application, 2021 – 2031 (USD Billion)
TABLE 36 Italy Neurovascular Devices Market Revenue, By End Use, 2021 – 2031 (USD Billion)
TABLE 37 Russia Neurovascular Devices Market Revenue, By Device Type, 2021 – 2031 (USD Billion)
TABLE 38 Russia Neurovascular Devices Market Revenue, By Application, 2021 – 2031 (USD Billion)
TABLE 39 Russia Neurovascular Devices Market Revenue, By End Use, 2021 – 2031 (USD Billion)
TABLE 40 Rest of Europe Neurovascular Devices Market Revenue, By Device Type, 2021 – 2031 (USD Billion)
TABLE 41 Rest of Europe Neurovascular Devices Market Revenue, By Application, 2021 – 2031 (USD Billion)
TABLE 42 Rest of Europe Neurovascular Devices Market Revenue, By End Use, 2021 – 2031 (USD Billion)
TABLE 43 Asia-Pacific Neurovascular Devices Market Revenue, By Country, 2021 – 2031 (USD Billion)
TABLE 44 Asia-Pacific Neurovascular Devices Market Revenue, By Device Type, 2021 – 2031 (USD Billion)
TABLE 45 Asia-Pacific Neurovascular Devices Market Revenue, By Application, 2021 – 2031 (USD Billion)
TABLE 46 Asia-Pacific Neurovascular Devices Market Revenue, By End Use, 2021 – 2031 (USD Billion)
TABLE 47 China Neurovascular Devices Market Revenue, By Device Type, 2021 – 2031 (USD Billion)
TABLE 48 China Neurovascular Devices Market Revenue, By Application, 2021 – 2031 (USD Billion)
TABLE 49 China Neurovascular Devices Market Revenue, By End Use, 2021 – 2031 (USD Billion)
TABLE 50 Japan Neurovascular Devices Market Revenue, By Device Type, 2021 – 2031 (USD Billion)
TABLE 51 Japan Neurovascular Devices Market Revenue, By Application, 2021 – 2031 (USD Billion)
TABLE 52 Japan Neurovascular Devices Market Revenue, By End Use, 2021 – 2031 (USD Billion)
TABLE 53 India Neurovascular Devices Market Revenue, By Device Type, 2021 – 2031 (USD Billion)
TABLE 54 India Neurovascular Devices Market Revenue, By Application, 2021 – 2031 (USD Billion)
TABLE 55 India Neurovascular Devices Market Revenue, By End Use, 2021 – 2031 (USD Billion)
TABLE 56 South Korea Neurovascular Devices Market Revenue, By Device Type, 2021 – 2031 (USD Billion)
TABLE 57 South Korea Neurovascular Devices Market Revenue, By Application, 2021 – 2031 (USD Billion)
TABLE 58 South Korea Neurovascular Devices Market Revenue, By End Use, 2021 – 2031 (USD Billion)
TABLE 59 Rest of Asia-Pacific Neurovascular Devices Market Revenue, By Device Type, 2021 – 2031 (USD Billion)
TABLE 60 Rest of Asia-Pacific Neurovascular Devices Market Revenue, By Application, 2021 – 2031 (USD Billion)
TABLE 61 Rest of Asia-Pacific Neurovascular Devices Market Revenue, By End Use, 2021 – 2031 (USD Billion)
TABLE 62 Middle East and Africa Neurovascular Devices Market Revenue, By Country, 2021 – 2031 (USD Billion)
TABLE 63 Middle East and Africa Neurovascular Devices Market Revenue, By Device Type, 2021 – 2031 (USD Billion)
TABLE 64 Middle East and Africa Neurovascular Devices Market Revenue, By Application, 2021 – 2031 (USD Billion)
TABLE 65 Middle East and Africa Neurovascular Devices Market Revenue, By End Use, 2021 – 2031 (USD Billion)
TABLE 66 GCC Neurovascular Devices Market Revenue, By Device Type, 2021 – 2031 (USD Billion)
TABLE 67 GCC Neurovascular Devices Market Revenue, By Application, 2021 – 2031 (USD Billion)
TABLE 68 GCC Neurovascular Devices Market Revenue, By End Use, 2021 – 2031 (USD Billion)
TABLE 69 North Africa Neurovascular Devices Market Revenue, By Device Type, 2021 – 2031 (USD Billion)
TABLE 70 North Africa Neurovascular Devices Market Revenue, By Application, 2021 – 2031 (USD Billion)
TABLE 71 North Africa Neurovascular Devices Market Revenue, By End Use, 2021 – 2031 (USD Billion)
TABLE 72 South Africa Neurovascular Devices Market Revenue, By Device Type, 2021 – 2031 (USD Billion)
TABLE 73 South Africa Neurovascular Devices Market Revenue, By Application, 2021 – 2031 (USD Billion)
TABLE 74 South Africa Neurovascular Devices Market Revenue, By End Use, 2021 – 2031 (USD Billion)
TABLE 75 Rest of Middle East & Africa Neurovascular Devices Market Revenue, By Device Type, 2021 – 2031 (USD Billion)
TABLE 76 Rest of Middle East & Africa Neurovascular Devices Market Revenue, By Application, 2021 – 2031 (USD Billion)
TABLE 77 Rest of Middle East & Africa Neurovascular Devices Market Revenue, By End Use, 2021 – 2031 (USD Billion)
TABLE 78 Latin America Neurovascular Devices Market Revenue, By Country, 2021 – 2031 (USD Billion)
TABLE 79 Latin America Neurovascular Devices Market Revenue, By Device Type, 2021 – 2031 (USD Billion)
TABLE 80 Latin America Neurovascular Devices Market Revenue, By Application, 2021 – 2031 (USD Billion)
TABLE 81 Latin America Neurovascular Devices Market Revenue, By End Use, 2021 – 2031 (USD Billion)
TABLE 82 Brazil Neurovascular Devices Market Revenue, By Device Type, 2021 – 2031 (USD Billion)
TABLE 83 Brazil Neurovascular Devices Market Revenue, By Application, 2021 – 2031 (USD Billion)
TABLE 84 Brazil Neurovascular Devices Market Revenue, By End Use, 2021 – 2031 (USD Billion)
TABLE 85 Argentina Neurovascular Devices Market Revenue, By Device Type, 2021 – 2031 (USD Billion)
TABLE 86 Argentina Neurovascular Devices Market Revenue, By Application, 2021 – 2031 (USD Billion)
TABLE 87 Argentina Neurovascular Devices Market Revenue, By End Use, 2021 – 2031 (USD Billion)
TABLE 88 Rest of Latin America Neurovascular Devices Market Revenue, By Device Type, 2021 – 2031 (USD Billion)
TABLE 89 Rest of Latin America Neurovascular Devices Market Revenue, By Application, 2021 – 2031 (USD Billion)
TABLE 90 Rest of Latin America Neurovascular Devices Market Revenue, By End Use, 2021 – 2031 (USD Billion)
TABLE 91 Company Market Ranking
TABLE 92 Regional Footprint
TABLE 93 Device Type Benchmarking
TABLE 94 Recent Developments
TABLE 95 Winning Imperatives

LIST OF FIGURES

FIG. 1 Market Segmentation
FIG. 2 Research Timeline
FIG. 3 Global Neurovascular Devices Market 2021-2031 (USD Billion)
FIG. 4 Global Neurovascular Devices Market Geographical Analysis (CAGR %)
FIG. 5 Global Neurovascular Devices Absolute Market Opportunity (USD Billion)
FIG. 6 Global Neurovascular Devices Market Attractiveness (USD Billion)
FIG. 7 Global Neurovascular Devices Market, By Device Type, 2021-2031 (USD Billion)
FIG. 8 Global Neurovascular Devices Market, By Application, 2021-2031 (USD Billion)
FIG. 9 Global Neurovascular Devices Market, By End Use, 2021-2031 (USD Billion)
FIG. 10 Research Methodology
FIG. 11 Research Process
FIG. 12 Bottom-Up Approach
FIG. 13 Top-Bottom Approach
FIG. 14 Market Dynamics Overview
FIG. 15 Porter's Five Forces Analysis
FIG. 16 Value Chain Analysis
FIG. 17 Macroeconomic Analysis
FIG. 18 Global Neurovascular Devices Market Revenue Share, By Device Type, 2023 and 2031 (%)
FIG. 19 Global Neurovascular Devices Market Revenue Share, By Application, 2023 and 2031 (%)
FIG. 20 Global Neurovascular Devices Market Revenue Share, By End Use, 2023 and 2031 (%)
FIG. 21 Global Neurovascular Devices Market Revenue Share, By Geographic Regions, 2023 and 2031 (%)
FIG. 22 Market Size and Projections, 2021 - 2031 (USD Billion)
FIG. 23 North America Neurovascular Devices Market Overview Share, By Countries, 2021 – 2031 (%)
FIG. 24 Market Size and Projections, 2021 - 2031 (USD Billion)
FIG. 25 Europe Neurovascular Devices Market Overview Share, By Countries, 2021 – 2031 (%)
FIG. 26 Market Size and Projections, 2021 - 2031 (USD Billion)
FIG. 27 Asia-Pacific Neurovascular Devices Market Overview Share, By Countries, 2021 – 2031 (%)
FIG. 28 Market Size and Projections, 2021 - 2031 (USD Billion)
FIG. 29 Middle East & Africa Neurovascular Devices Market Overview Share, By Countries, 2021 – 2031 (%)
FIG. 30 Market Size and Projections, 2021 - 2031 (USD Billion)
FIG. 31 Latin America Neurovascular Devices Market Overview Share, By Countries, 2021 – 2031 (%)
FIG. 32 Key Strategic Development
FIG. 33 Key Facts
FIG. 34 Financial Overview
FIG. 35 SWOT Analysis